Literature DB >> 10634628

Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy.

M Winter1, W Eberhardt, C Scholz, A Reichenbach.   

Abstract

PURPOSE: To determine the effect of perfluorocarbon liquid (PFCL)-induced abolition of potassium siphoning by the vitreal end feet of Miller cells.
METHODS: Porcine eyecups were filled with stained balanced salt solution and PFCLs (perfluorodecalin, perfluorooctane, perfluoroperhydrophenanthrene or the semifluorocarbon perfluorohexylhexane). With optical coherence tomography, the distance between PFCL and retina was determined, and the size of the aqueous space covering the retinal surface was estimated. The data were used to calculate the retinal potassium siphoning into small aqueous volumes.
RESULTS: The distance between PFCL and retinal surface was found to be less than 5 to 10 microm with any PFCL tested. The resultant volume of the aqueous space was too small to act as a sufficient sink for K+ ion siphoning.
CONCLUSIONS: A certain threshold volume of vitreal fluid seems to be necessary for efficient buffering of intraretinal increases of K+ and perhaps other (e.g., H+) ions through the Müller cells. When the aqueous fluid is replaced by a PFCL (or by silicone oil) for longer periods, the outer retina becomes subject to long-lasting K+ accumulation, and consequent neurodegeneration and reactive gliosis occurs. The authors propose to search for new vitreous-substituting fluids with the capability to dissolve ions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10634628

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  31 in total

1.  [Advantages and disadvantages of heavy silicone oil].

Authors:  B Kirchhof
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

Review 2.  [Characteristic features of optic nerve ganglion cells and approaches for neuroprotection. From intracellular to capillary processes and therapeutic considerations].

Authors:  R H W Funk; K-G Schmidt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

3.  What pressure is exerted on the retina by heavy tamponade agents?

Authors:  David Wong; Rachel Williams; Theodor Stappler; Carl Groenewald
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-17       Impact factor: 3.117

4.  Visual loss following removal of intraocular silicone oil.

Authors:  S Cazabon; C Groenewald; I A Pearce; D Wong
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

5.  Secondary paracentral retinal holes following internal limiting membrane removal.

Authors:  P Steven; H Laqua; D Wong; H Hoerauf
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

6.  Central scotoma associated with intraocular silicone oil tamponade develops before oil removal.

Authors:  E N Herbert; M Habib; D Steel; T H Williamson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-27       Impact factor: 3.117

7.  Vision loss associated with the use and removal of intraocular silicone oil.

Authors:  Patrick D Williams; Christopher G Fuller; Ingrid U Scott; Dwain G Fuller; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2008-12

8.  A decrease in macular microvascular perfusion after retinal detachment repair with silicone oil.

Authors:  Wei Fang; Jing Zhai; Jian-Bo Mao; Hai-Dong Li; Zhen-Bin Qian; Chao-Qiao Chen; Jia-Hao Xu; Li-Jun Shen; Yi-Qi Chen
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

Review 9.  Heavy and standard silicone oil: intraocular inflammation.

Authors:  Andrea Russo; Francesco Morescalchi; Simone Donati; Elena Gambicorti; Claudio Azzolini; Ciro Costagliola; Francesco Semeraro
Journal:  Int Ophthalmol       Date:  2017-03-13       Impact factor: 2.031

Review 10.  [New developments in retinal detachment surgery].

Authors:  U Bartz-Schmidt; P Szurman; D Wong; B Kirchhof
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.